152 related articles for article (PubMed ID: 38649936)
1. Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Moon JY; Lee SH; Yim SV; Hwang HS; Jeong K
BMC Nephrol; 2024 Apr; 25(1):142. PubMed ID: 38649936
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy.
Segarra A; Carnicer C; Jatem E; Martin M; Molina M; Perich C; Martinez C
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232037
[TBL] [Abstract][Full Text] [Related]
3. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
4. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
[TBL] [Abstract][Full Text] [Related]
5. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
Shin JR; Kim SM; Yoo JS; Park JY; Kim SK; Cho JH; Jeong KH; Lee TW; Ihm CG
Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
[TBL] [Abstract][Full Text] [Related]
7. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
Ranieri E; Gesualdo L; Petrarulo F; Schena FP
Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
[TBL] [Abstract][Full Text] [Related]
8. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
Niu X; Zhang S; Shao C; Guo Z; Wu J; Tao J; Zheng K; Ye W; Cai G; Sun W; Li M
PeerJ; 2023; 11():e15125. PubMed ID: 37065697
[TBL] [Abstract][Full Text] [Related]
9. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
Liu LL; Jiang Y; Wang LN; Liu N
Clin Exp Immunol; 2012 Aug; 169(2):148-55. PubMed ID: 22774989
[TBL] [Abstract][Full Text] [Related]
10. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
11. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
Ji FP; Wen L; Zhang YP; Liu EP; Wen JG
Int Urol Nephrol; 2022 Jun; 54(6):1287-1294. PubMed ID: 34585312
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053
[TBL] [Abstract][Full Text] [Related]
13. The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.
Xu X; Huang X; Chen Y; Li J; Shen M; Hou Y; Lin X; Lin Q; Liu X; Bao K; Wang L; Yang H; Liu L; Zou C
Int Urol Nephrol; 2022 Feb; 54(2):323-330. PubMed ID: 33871780
[TBL] [Abstract][Full Text] [Related]
14. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
[TBL] [Abstract][Full Text] [Related]
15. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
Torres DD; Rossini M; Manno C; Mattace-Raso F; D'Altri C; Ranieri E; Pontrelli P; Grandaliano G; Gesualdo L; Schena FP
Kidney Int; 2008 Feb; 73(3):327-33. PubMed ID: 17943082
[TBL] [Abstract][Full Text] [Related]
16. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
[TBL] [Abstract][Full Text] [Related]
19. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
20. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
